Coronavirus

CureVac Vaccine Shows Immune Response

By
OB Bureau

London: Germany-based vaccine maker CureVac on Monday announced that early trials of its candidate CvnCoV have triggered a safe and immense response among participants in its Phase 1 trial.

The vaccine produced strong binding and neutralising antibody responses in addition to first indication of T cell activation, the company said.

More than 250 individuals aged 18 to 60 years were involved in the trial.

The vaccine was administered intramuscularly with escalating dose levels of 2, 4, 6, 8 and 12 microgram on days 1 and 29.

The vaccine was also tried on 10 individuals who had previously had COVID-19  (seropositives).

“We are very encouraged by the interim Phase 1 data. It represents a critical milestone in our Covid-19 vaccine programme and strongly supports the advancement of our vaccine candidate,” Franz-Werner Haas, Chief Executive Officer of CureVac, said in a statement.

“Following further data readouts and discussion with regulatory authorities, we remain fully committed and on track to initiate a pivotal Phase 2b/3 trial before the end of 2020.”

There were no serious side-effects. At 12 microgram, fatigue, headache, chills, muscle pain, and to a lesser extent, fever were seen, the company said. These were resolved rapidly.

“These initial data show a robust and highly efficient immune response to our natural mRNA (messenger ribonucleic acid)-based CVnCoV vaccine candidate, including antibody and initial T cell responses at the level of a relevant panel of symptomatic convalescent patients,” said Mariola Fotin-Mleczek, Chief Technology Officer of CureVac.

 

OB Bureau

Recent Posts

New Artist To Play King Kansa Role During Dhanu Yatra In Odisha’s Bargarh

Bargarh: A new artist will be selected to play the mythological character King Kansa during…

November 22, 2024

Shah Rukh’s Daughter Suhana Khan Brutally Trolled For Vivo Ad [Watch]

Mumbai: Suhana Khan will be making her Bollywood debut with ‘King’ along with her superstar…

November 22, 2024

Badshah Comes Out In Support Of Diljit Dosanjh In Alcohol Controversy

New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…

November 22, 2024

World War 3 Has Begun, Says Ukraine’s Former Military Chief

New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…

November 22, 2024

3 Arrested With Fake IPS Officers’ Uniforms, Identity Cards In Odisha’s Balangir

Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…

November 22, 2024

‘I Want To Talk’: Twitterati Lauds Abhishek Bachchan, Say He Is Better Than Amitabh

Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…

November 22, 2024

Cash-For-Vote Row: BJP Leader’s Defamation Notice Against Rahul Gandhi, Kharge

New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…

November 22, 2024

CM Mohan Majhi Attends ‘Odisha State Day’ Celebrations At IITF In Delhi

Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…

November 22, 2024